An Act to protect 340B providers

HD 3592, "An Act to protect 340B providers," ensures healthcare facilities participating in the federal 340B drug discount program (like community health centers and hospitals) are treated fairly by insurance companies, pharmacy benefit managers, and drug manufacturers. The bill prohibits payors from reimbursing 340B providers at lower rates than non-340B providers, imposing extra fees, requiring special billing for 340B drugs, or creating administrative barriers like unnecessary data demands. It also stops drug manufacturers from interfering with the delivery of 340B drugs to contracted pharmacies or denying access to these drugs. This legislation safeguards the program’s ability to provide discounted medications to eligible patients without unfair financial or administrative hurdles.